BRPI0912589A2 - "excipiente para comprimidos composto de novo manitol esférico" - Google Patents

"excipiente para comprimidos composto de novo manitol esférico"

Info

Publication number
BRPI0912589A2
BRPI0912589A2 BRPI0912589A BRPI0912589A BRPI0912589A2 BR PI0912589 A2 BRPI0912589 A2 BR PI0912589A2 BR PI0912589 A BRPI0912589 A BR PI0912589A BR PI0912589 A BRPI0912589 A BR PI0912589A BR PI0912589 A2 BRPI0912589 A2 BR PI0912589A2
Authority
BR
Brazil
Prior art keywords
tablet excipient
new spherical
spherical mannitol
excipient composed
mannitol
Prior art date
Application number
BRPI0912589A
Other languages
English (en)
Inventor
Imaoka Maki
Satomi Jin
Original Assignee
Mitsubishi Shoji Foodtech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Shoji Foodtech Co Ltd filed Critical Mitsubishi Shoji Foodtech Co Ltd
Publication of BRPI0912589A2 publication Critical patent/BRPI0912589A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • A61K9/1623Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/29Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
BRPI0912589A 2008-08-18 2009-08-14 "excipiente para comprimidos composto de novo manitol esférico" BRPI0912589A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008209851 2008-08-18
PCT/JP2009/064334 WO2010021300A1 (ja) 2008-08-18 2009-08-14 新規マンニトール打錠用賦形剤

Publications (1)

Publication Number Publication Date
BRPI0912589A2 true BRPI0912589A2 (pt) 2015-10-13

Family

ID=41707178

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0912589A BRPI0912589A2 (pt) 2008-08-18 2009-08-14 "excipiente para comprimidos composto de novo manitol esférico"

Country Status (6)

Country Link
US (1) US8895141B2 (pt)
EP (1) EP2327424A4 (pt)
JP (1) JP5650532B2 (pt)
BR (1) BRPI0912589A2 (pt)
CA (1) CA2734847C (pt)
WO (1) WO2010021300A1 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5876418B2 (ja) * 2010-12-28 2016-03-02 大鵬薬品工業株式会社 口腔内崩壊錠剤
JP6208931B2 (ja) * 2011-09-07 2017-10-04 三菱商事フードテック株式会社 硬度を高めた口腔内崩壊錠およびその製造方法
BR112014026351B1 (pt) * 2012-04-25 2022-09-27 Spi Pharma Inc Composições compreendendo microesferas e formulação farmacêutica contendo tais composições
JP6004882B2 (ja) * 2012-10-15 2016-10-12 三菱商事フードテック株式会社 圧縮成形に用いるためのマンニトール賦形剤及びこれを含有する錠剤
KR102142257B1 (ko) * 2013-04-04 2020-08-07 다이이찌 산쿄 가부시키가이샤 아미노카르복실산의 염의 고형 조성물
WO2015046489A1 (ja) * 2013-09-30 2015-04-02 第一三共株式会社 スプレードライ法を用いたD-マンニトールα型結晶の選択的製造方法
JP6666731B2 (ja) * 2015-01-29 2020-03-18 三菱商事ライフサイエンス株式会社 錠剤の衝撃耐性向上賦形剤
ES2821733T3 (es) 2015-03-19 2021-04-27 Daiichi Sankyo Co Ltd Preparación sólida que contiene colorante
US10561628B2 (en) 2015-03-19 2020-02-18 Daiichi Sankyo Company, Limited Solid preparation including antioxidant
FR3038836B1 (fr) 2015-07-17 2017-07-14 Roquette Freres Granules de mannitol pour compression directe
JP6660139B2 (ja) * 2015-10-05 2020-03-04 三菱商事ライフサイエンス株式会社 錠剤の衝撃耐性改善賦形剤
JP2017125001A (ja) * 2016-01-13 2017-07-20 三菱商事フードテック株式会社 マンニトール粉末を用いた苦味抑制方法
JP2018030840A (ja) * 2016-08-23 2018-03-01 ライオン株式会社 錠剤、コーティング錠、錠剤の製造方法及びコーティング錠の製造方法
US20210069113A1 (en) * 2019-09-11 2021-03-11 Modavar Pharmaceuticals LLC Solid unit dosage form for dose individualized drug delivery
WO2021095092A1 (ja) * 2019-11-11 2021-05-20 大塚製薬株式会社 口腔内崩壊錠

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3145146A (en) * 1961-10-31 1964-08-18 Warner Lambert Pharmaceutical Modified mannitol for pharmaceutical tablets
JPS6185330A (ja) * 1984-10-04 1986-04-30 Fuji Kagaku Kogyo Kk 直打用賦形薬の製造法
NL8600731A (nl) 1986-03-21 1987-10-16 Dmv Campina Bv Verbeterde gesproeidroogde lactose en werkwijze ter bereiding ervan.
JP3349535B2 (ja) 1993-01-12 2002-11-25 フロイント産業株式会社 球形顆粒の製造方法
FR2710637B1 (fr) 1993-09-28 1995-12-08 Roquette Freres Mannitol pulvérulent de friabilité modérée et son procédé de préparation.
EP0820237A4 (en) * 1995-01-25 1999-01-20 Wrigley W M Jun Co IMPROVED DUST MIXTURE AND METHOD FOR PRODUCING CHEWING GUM WITH YOUR HELP
JP3910939B2 (ja) 1997-07-23 2007-04-25 フロイント産業株式会社 単一物質球形粒、それらを用いた食品、医薬及びそれらの製法
JP3447042B2 (ja) * 1997-07-23 2003-09-16 フロイント産業株式会社 単一物質球形粒の製造方法
JP3491887B2 (ja) 1999-04-28 2004-01-26 フロイント産業株式会社 糖アルコール造粒物集合体の製法
JP2001058944A (ja) 1999-06-18 2001-03-06 Takeda Chem Ind Ltd 速崩壊性固形製剤
MY148466A (en) 2001-10-26 2013-04-30 Merck Frosst Canada Ltd Granule formulation
JP2003192582A (ja) * 2001-12-12 2003-07-09 Merck Patent Gmbh ナプロキセンナトリウムを含む速放性錠剤
DE10161402A1 (de) 2001-12-13 2003-06-18 Merck Patent Gmbh Verfahren zur Herstellung von direkt tablettierbarem beta-Mannit
JP2003192585A (ja) 2001-12-27 2003-07-09 Lion Corp 口腔用組成物
JP2005306770A (ja) 2004-04-21 2005-11-04 Toa Eiyo Ltd 口腔内速崩壊型製剤及びその製造方法
JP2006028130A (ja) 2004-07-21 2006-02-02 Toa Eiyo Ltd ピモベンダン経口投与製剤
JP2007197438A (ja) * 2005-12-28 2007-08-09 Dainippon Sumitomo Pharma Co Ltd 口腔内速崩壊錠剤
US20080085309A1 (en) 2006-09-14 2008-04-10 Astellas Pharma Inc. Rapidly disintegrating tablets in buccal cavity and manufacturing method thereof
WO2008146590A1 (ja) * 2007-05-28 2008-12-04 Mitsubishi Shoji Foodtech Co., Ltd. 球形マンニトール結晶粒子

Also Published As

Publication number Publication date
EP2327424A1 (en) 2011-06-01
EP2327424A4 (en) 2014-10-01
CA2734847A1 (en) 2010-02-25
JPWO2010021300A1 (ja) 2012-01-26
CA2734847C (en) 2016-08-30
WO2010021300A1 (ja) 2010-02-25
US20110135927A1 (en) 2011-06-09
US8895141B2 (en) 2014-11-25
JP5650532B2 (ja) 2015-01-07

Similar Documents

Publication Publication Date Title
BRPI0912589A2 (pt) "excipiente para comprimidos composto de novo manitol esférico"
BRPI0913379A2 (pt) formulações farmacêuticas sólidas compreendendo bibw 2992
BR112012001604A2 (pt) composição para cuidado pessoal
SMT201500140B (it) Composizione per inibire l'espressione genica e suoi usi
BRPI1011876A2 (pt) "composição farmacêutica estável e métodos de uso da mesma"
DK2257304T3 (da) Poloxamer med langvarig frigivelse indeholdende farmaceutiske sammensætninger
BR112013000705A2 (pt) "composição de limpeza para cuidado pessoal"
EP2308493A4 (en) ENHANCING OR THERAPEUTIC AGENT FOR DYSLIPIDEMIA
BRPI1012116A2 (pt) composição farmacêutica para o tratamento de doenças cardíacas
BRPI0919466A2 (pt) composição farmacêutica para liberação modificada
BRPI0810978A2 (pt) "partícula esférica de manitol cristalino"
BRPI0811188A2 (pt) Composições fosfolipídicas para cuidados de lentes de contato e conservação de composições farmacêuticas.
BR112012004526A2 (pt) "estrutura de suporte e contenção para pessoas"
BRPI0815970A2 (pt) composição para cuidado pessoal
BRPI0906058A2 (pt) "jarra para produtos cosméticos"
BRPI1013245A2 (pt) "composto para o tratamento de distúrbios metabólicos"
BR112012025270A2 (pt) "composição de cuidados pessoais"
BRPI1006666A2 (pt) " composição farmacêutica e uso de uma composição farmacêutica"
IL201923A0 (en) Aryloxy-and heteroaryloxy-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
SMT201600041B (it) Agenti terapeutici 713
BR112012005678A2 (pt) composição para cuidado pessoal
IL219963A (en) Pharmaceutical composition containing transcorsorcaline hydrochloride and mannitol and its use
IT1395539B1 (it) Piede d'appoggio
BRPI1007237A2 (pt) composição farmacêutica compreendendo aleglitazar
NO20083139L (no) Anvendelse av hyllebærekstrakt

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 14A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2735 DE 06-06-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.